Table 3.
Risk factors | Categories or units | No recurrence vs multiple recurrence | Single recurrence vs multiple recurrence | P wald (df) | ||||
---|---|---|---|---|---|---|---|---|
B | Sig | aOR (95% CI) | B | Sig | aOR (95% CI) | |||
Age | < 60 | 0.18 | 0.837 | 1.19 (0.21–6.78) | 0.26 | 0.797 | 1.30 (0.17–9.74) | 0.888 |
Sex | Male | 1.15 | 0.294 | 3.15 (0.36–27) | − 15.35 | 0.990 | 2.14E−7 | 0.989 |
Hypertension | No | 0.18 | 0.856 | 1.19 (0.17–8.33) | 0.12 | 0.918 | 1.12 (0.11–11.24) | 0.932 |
Diabetics | No | − 16.16 | 0.995 | 9.54E−8 | − 16.81 | 0.995 | 4.98E−8 | 0.740 |
Orthostatic hypotension | No | − 15.71 | 0.000 | 1.50E−7 (1.77E−8 to 1.27E−6) | − 14.86 | 3.48E−7 | 0.439 | |
Medicationsa | No | − 15.75 | 0.000 | 1.44E−7 (4.07E−8 to 5.12E−7) | − 16.72 | 5.47E−8 | 0.132 |
BPPV Benign paroxysmal positional vertigo, B unstandardized coefficient. Sig. significance probability, aOR adjusted odds ratio, CI confidence interval, df degrees of freedom.
aThe diseases of the drug-taking were arrhythmia, heart disease, antidepressant, thyroid disease, hypnotic and prostate disease.
p values were calculated using polychotomous logistic regression analysis or Wald test.
Bold values indicate statistical significance (p < 0.05).